AFX: (4S,5S)-4-(6-amino-9H-purin-9-yl)-3-fluoro-5-hydroxy-2-(hydroxymethyl)cyclopent-2-en-1-one
AFX is a Ligand Of Interest in 3NJ4 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3NJ4_AFX_D_604 | 51% | 9% | 0.19 | 0.947 | 3.35 | 1.32 | 4 | 1 | 0 | 0 | 100% | 1 |
| 3NJ4_AFX_A_601 | 48% | 9% | 0.201 | 0.945 | 3.34 | 1.3 | 7 | 1 | 0 | 0 | 100% | 1 |
| 3NJ4_AFX_C_603 | 38% | 10% | 0.218 | 0.922 | 3.26 | 1.34 | 3 | 1 | 0 | 0 | 100% | 1 |
| 3NJ4_AFX_B_602 | 36% | 11% | 0.244 | 0.94 | 3.23 | 1.24 | 5 | 1 | 0 | 0 | 100% | 1 |
